Inon Schenker: Difference between revisions
WikiModEn2 (talk | contribs) Wikify. |
m wikify Israel |
||
| Line 55: | Line 55: | ||
{{Citation | {{Citation | ||
|Title=David Llewellyn's Account of NHPC 2009 | |Title=David Llewellyn's Account of NHPC 2009 | ||
|Text=At one of the last sessions, the speaker from "Operation Abraham," an Israel-based group that apparently hopes to be engaged to assist the U.S. in circumcising black and Hispanic males, put a photo of an [[intact]] male up on the screen. The figure of an elephant had been drawn around the penis so that the intact penis looked like an elephant's trunk. The words "Yes! A circumcision please!" had been added to the photo. I remonstrated loudly until this smear against [[intact]] males was taken down. I then promptly left the session. I am still awaiting a deserved, written, direct apology from Dr. [[Peter Kilmarx]], Chief of the Epidemiology Branch of the Division of [[HIV]]/[[AIDS]] Prevention of the CDC, who was in attendance and from whom I demanded an apology. | |Text=At one of the last sessions, the speaker from "Operation Abraham," an [[Israel]]-based group that apparently hopes to be engaged to assist the U.S. in circumcising black and Hispanic males, put a photo of an [[intact]] male up on the screen. The figure of an elephant had been drawn around the penis so that the intact penis looked like an elephant's trunk. The words "Yes! A circumcision please!" had been added to the photo. I remonstrated loudly until this smear against [[intact]] males was taken down. I then promptly left the session. I am still awaiting a deserved, written, direct apology from Dr. [[Peter Kilmarx]], Chief of the Epidemiology Branch of the Division of [[HIV]]/[[AIDS]] Prevention of the CDC, who was in attendance and from whom I demanded an apology. | ||
|Author=Llewellyn, D. | |Author=Llewellyn, D. | ||
|Source=NHPC 2009 | |Source=NHPC 2009 | ||
| Line 85: | Line 85: | ||
|accessdate=2022-07-16 | |accessdate=2022-07-16 | ||
}}</ref> | }}</ref> | ||
==Circumcision does not prevent HIV infection== | ==Circumcision does not prevent HIV infection== | ||
=== Population-based studies === | === Population-based studies === | ||
{{Population-based studies}} | {{Population-based studies}} | ||
===Two African surveys=== | ===Two African surveys=== | ||
The previously reported studies were from developed Western nations. Now we have information from Sub_Saharan Africa. | The previously reported studies were from developed Western nations. Now we have information from Sub_Saharan Africa. | ||
| Line 94: | Line 96: | ||
In his first report, Garenne presented the findings from a study in Lesotho, the enclave in South Africa. He reported: | In his first report, Garenne presented the findings from a study in Lesotho, the enclave in South Africa. He reported: | ||
<blockquote> | <blockquote> | ||
In couple studies, the effect of circumcision and VMMC on HIV was not significant, with similar transmission from female to male and male to female. The study questions the amount of effort and money spent on VMMC in Lesotho.<ref name="garenne2022A">{{REFjournal | In couple studies, the effect of circumcision and VMMC on HIV was not significant, with similar transmission from female to male and male to female. The study questions the amount of effort and money spent on VMMC in Lesotho.<ref name="garenne2022A">{{REFjournal | ||
| Line 113: | Line 116: | ||
In his second report, Garenne (2022) presented information from six Sub-Saharan African nations (Eswatini, Lesotho, Malawi, Namibia, Zambia, Zimbabwe). He reported: | In his second report, Garenne (2022) presented information from six Sub-Saharan African nations (Eswatini, Lesotho, Malawi, Namibia, Zambia, Zimbabwe). He reported: | ||
<blockquote> | <blockquote> | ||
"Results matched earlier observations made in South Africa that [[circumcised]] and [[intact]] men had similar levels of HIV infection."<ref name="garenne2022B">{{REFjournal | "Results matched earlier observations made in South Africa that [[circumcised]] and [[intact]] men had similar levels of HIV infection."<ref name="garenne2022B">{{REFjournal | ||
| Line 140: | Line 144: | ||
|accessdate=2022-11-06 | |accessdate=2022-11-06 | ||
}}</ref></blockquote> | }}</ref></blockquote> | ||
{{REF}} | {{REF}} | ||